
Max Miller Periodic Transaction Report
Filed Jul 26, 2026 · House Clerk · 1 transaction
U.S. Representative · R · OH-07 · All trades by Max Miller
On July 26, 2026, Rep. Max Miller (R-OH-07) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Jul 22, 2026.
The one asset reported, Riverside Acceleration Capital Opportunity Fund II (GLAS Funds, LP), is listed without a stock ticker. The filer coded it as "Hedge Funds & Private Equity Funds (non-EIF)" on the House form.
Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 4 days.
Source document: House Clerk filing 20035075
Sample · the intelligence layer
Max Miller · Bought · Jul 22 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Max Miller
Get an email the moment Max Miller files the next one. Free, no card, no spam.
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Jul 22, 2026 | — | Riverside Acceleration Capital Opportunity Fund II (GLAS Funds, LP) Hedge Funds & Private Equity Funds (non-EIF) | buy | — | $1K–$15K | 4d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Max Miller
- PTR filed Oct 27, 20262 trades
- PTR filed Sep 27, 20261 trade
- PTR filed Jul 1, 20262 trades · CCLFX
- PTR filed May 29, 20262 trades
- PTR filed Apr 28, 20263 trades
- PTR filed Mar 30, 20266 trades
← All congressional filings, newest firstFiled Jul 26, 2026July 2026 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →